Rtw Investments, LP Jounce Therapeutics, Inc. Transaction History

Rtw Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $2.04 Million - $3.68 Million	747,908 Added 17.16%	5,106,341 $11.9 Million
Q2 2022 Aug 15, 2022	SELL	$2.8 - $7.67 $901,541 - $2.47 Million	-321,979 Reduced 6.88%	4,358,433 $13.2 Million
Q1 2022 May 16, 2022	BUY	$6.01 - $8.54 $10.9 Million - $15.5 Million	1,817,214 Added 63.47%	4,680,412 $31.8 Million
Q4 2021 Feb 14, 2022	BUY	$7.11 - $9.64 $10.4 Million - $14.1 Million	1,466,995 Added 105.07%	2,863,198 $23.9 Million
Q3 2021 Nov 15, 2021	BUY	$5.04 - $8.73 $7.04 Million - $12.2 Million	1,396,203 New	1,396,203 $10.4 Million

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.